SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A bearish BMF short report questioning SELLASs REGAL Phase 3 trial design, statistical power and valuation drove the selloff and intensified attention ahead of the delayed 80th event and topline readout. Traders remain divided, with bullish participants disputing the reports assumptions and focusing on prolonged patient survival, while bearish voices warn the trial could be underpowered or fail its endpoint.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Speculation that Nvidia could use Lumens fiber network for a large AI connectivity buildout is driving attention, reinforced by Lumens completed Alkira acquisition and broader AI-networking strategy. Traders remain divided, with bulls expecting major contract or investment news while skeptics point to managements silence, ongoing legacy-business declines, and the lack of a share-buyback announcement.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswaps UNIfication governance proposalcentered on activating the protocol fee switch and initiating a large UNI burnis driving attention, with traders viewing it as a potential shift toward revenue capture and deflationary tokenomics. The community is broadly optimistic, though some remain cautious about approval, the burns practical impact, and weak broader altcoin conditions.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Partner approvals of the XFG-adapted Nuvaxovid for the 20262027 season in the U.S., EU and Japan are driving discussion, with traders focused on potential royalty growth and expanded commercialization by Sanofi and Takeda. Attention is also being amplified by Modernas cancer-vaccine success, prompting speculation that Novavaxs Matrix-M adjuvant could attract an oncology partnership, while skeptics argue the approvals and unconfirmed deal theories may not materially change near-term results.

ETF Opportunities Trust - T-Rex 2X Long MSTR Daily Target ETF

T-Rex 2X Long MSTR Daily Target ETF

A scheduled 1-for-10 reverse split is driving attention, with traders debating its impact on options, liquidity, and the ETFs ongoing leverage decay. The community remains split between bullish bets on a Bitcoin/MSTR rebound and warnings that repeated reverse splits and daily compounding can erode long-term holdings.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Discussion centers on Tezos prolonged selloff and repeated multi-year lows, with bearish traders citing ongoing token issuance, staking dilution, and weak market interest. Some participants view the depressed price as a bottoming opportunity and anticipate an altcoin rebound, but skepticism and calls for further downside dominate.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Colas strong quarterly earnings beat and raised full-year outlook, supported by resilient beverage volumes, have driven renewed attention and a rally toward record highs. Traders largely view KO as a defensive beneficiary of rotation out of technology, though some argue the move has left the stock overbought and richly valued.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

Persistent low volatility and resilient equities are drawing attention to UVXY as traders debate why it is underperforming spot VIX and failing to hedge market pullbacks. The dominant explanation is its exposure to VIX futures, contango and roll decay, though some traders allege suppression or expect a volatility spike from geopolitical, inflation and rate risks.

Dogelon Mars

Persistent community-driven promotion and repeated trending status are keeping Dogelon Mars in focus, with traders speculating about a broader crypto rally, regulatory clarity and possible Elon Musk or SpaceX-related attention. Skeptics counter that the token lacks confirmed endorsements, meaningful burns or project updates and has continued to underperform, making the discussion largely promotional and speculative.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is drawing attention amid a broad post-SpaceX-IPO selloff and capital rotation out of space stocks, compounded by community concern over its large ATM offering and limited management updates ahead of earnings. Traders are split between viewing the decline as an oversold, sector-wide reset and warning that dilution, weak momentum, and an earnings-dependent recovery could keep pressure on the shares.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harvest Health & Recreation, Inc. engages in the cultivation, processing, distribution, and sale of cannabis and cannabis related products. The firm assembles and packages cannabis finished goods through the Inhalable and Ingestible segments. The Inhalable segment includes flower, dabbable concentrates such as budder, wax, crumble, shatter, live resin, sauce, terpene sugar, pre-filled vaporizer pens, and cartridges. The Ingestible segment includes capsules, tinctures, and cannabis product edibles including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips. The company was founded by Jason Vedadi, Steven M. White, Paul Nowak, and Matt Waltz on November 20, 2007 and is headquartered in Tallahassee, FL.

Harvest Health & Recreation Inc - Ordinary Shares (Sub Voting)

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

HRVSF Harvest Health & Recreation Inc

Connect Stocktwits to ChatGPT

Latest HRVSF News